August 31, 2018 by Chain Drug Review
CVS Health, Dave Denton, Larry Merlo, Morgan Stanley Global Healthcare Conference
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health announced that Larry Merlo, president and chief executive officer, and Dave Denton, executive vice president and chief financial officer, will be presenting to investors at the Morgan Stanley Global Healthcare Conference on September 13, 2018, at approximately 8:35 a.m. EST. An audio webcast of the event will be broadcast simultaneously
March 1, 2017 by CDR Blog and Chain Drug Review
Advisor Access, CVS Health, CVS Pharmacy, Dave Denton, Maintenance Choice 3.0, prescription drug prices, repeal of the Affordable Care Act, Target's pharmacy business
CDR Blog
CVS Health’s pharmacy care assets position the company well for growth, even in an evolving health care arena set for further change under a new presidential administration, executive VP and CFO Dave Denton said. In an interview posted this week on investment intelligence website Advisor Access, Denton outlined CVS’ strengths — namely, its integrated retail
December 15, 2016 by Chain Drug Review
Brian Tanquilut, CVS Analyst Day, CVS Health, Dave Denton, Jefferies, Larry Merlo, PBM market, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — CVS Health’s integrated pharmacy care model makes it a “partner of choice” in the health care arena, president and chief executive officer Larry Merlo said at the company’s annual Analyst Day event in Manhattan. Merlo and senior CVS Health executives gathered in New York on Thursday to give the investment community an
January 5, 2015 by Chain Drug Review
Analyst Day, CVS Health, CVS/caremark, CVS/minuteclinic, CVS/pharmacy, Dave Denton, Helena Foulkes, Jon Roberts, Larry Merlo, PBM, specialty pharmacy
2015, Business, Issue 01-05-2015, News
NEW YORK — CVS Health “has made the right moves,” and is “very excited about the enterprise that we have become,” president and chief executive officer Larry Merlo said at the company’s annual Analyst Day here. CVS is well positioned to meet the changing needs of consumers, payers and providers with its integrated retail pharmacy,